Muscle-invasive urothelial carcinoma of the urinary bladder (UCB) often recurs following radical cystectomy (RC). An altered expression of sex-steroid hormone receptors has been associated with oncological outcomes of UCB and may represent therapeutic targets. Here the expression of different hormone receptors was measured on mRNA levels in patients treated by RC and associated with outcomes. Androgen receptor (AR), estrogen receptor 1 (ESR1), and progesterone receptor (PGR) mRNA expression was assessed by quantitative reverse transcription polymerase chain reaction (RT-qPCR) in RC samples of 87 patients with a median age of 66 (39-88) years. Univariate and multivariate analyses were performed to test associations with pathological and clin...
Emerging preclinical findings have indicated that steroid hormone receptor signaling plays an import...
PURPOSE: To examine the usefulness of various receptor tyrosine kinase expressions as prognostic mar...
Expression of ESR1, PGR, HER2 and Ki67 is important for risk stratification and therapy in breast ca...
INTRODUCTION: Gender-specific differences have led to the androgen receptor (AR) being considered a ...
Emerging preclinical evidence suggests the involvement of sex hormones and their receptor signals in...
INTRODUCTION: High-risk non-muscle-invasive bladder cancer (NMIBC) remains challenging given the hig...
The role of the androgen receptor (AR) in non-muscle-invasive bladder cancer (NMIBC) remains controv...
Abstract Background Non-muscular invasive bladder cancer (NMIBC) has a high risk of recurrence. As a...
Contains fulltext : 237636.pdf (Publisher’s version ) (Open Access)Bladder urothel...
In order to evaluate the potential prognostic/predictive role of androgen receptor (AR) expression i...
Objectives: The role of estrogens in human bladder cancer still remains to be resolved. This study w...
There is a substantial amount of preclinical or clinical evidence suggesting that steroid hormone re...
The study was undertaken to evaluate the possible role of Androgen Receptor (AR) in relation to tumo...
INTRODUCTION: Gene expression analyses have identified similarities between bladder and breast cance...
This study aims to determine the significance of androgen receptor (AR) expression in urothelial car...
Emerging preclinical findings have indicated that steroid hormone receptor signaling plays an import...
PURPOSE: To examine the usefulness of various receptor tyrosine kinase expressions as prognostic mar...
Expression of ESR1, PGR, HER2 and Ki67 is important for risk stratification and therapy in breast ca...
INTRODUCTION: Gender-specific differences have led to the androgen receptor (AR) being considered a ...
Emerging preclinical evidence suggests the involvement of sex hormones and their receptor signals in...
INTRODUCTION: High-risk non-muscle-invasive bladder cancer (NMIBC) remains challenging given the hig...
The role of the androgen receptor (AR) in non-muscle-invasive bladder cancer (NMIBC) remains controv...
Abstract Background Non-muscular invasive bladder cancer (NMIBC) has a high risk of recurrence. As a...
Contains fulltext : 237636.pdf (Publisher’s version ) (Open Access)Bladder urothel...
In order to evaluate the potential prognostic/predictive role of androgen receptor (AR) expression i...
Objectives: The role of estrogens in human bladder cancer still remains to be resolved. This study w...
There is a substantial amount of preclinical or clinical evidence suggesting that steroid hormone re...
The study was undertaken to evaluate the possible role of Androgen Receptor (AR) in relation to tumo...
INTRODUCTION: Gene expression analyses have identified similarities between bladder and breast cance...
This study aims to determine the significance of androgen receptor (AR) expression in urothelial car...
Emerging preclinical findings have indicated that steroid hormone receptor signaling plays an import...
PURPOSE: To examine the usefulness of various receptor tyrosine kinase expressions as prognostic mar...
Expression of ESR1, PGR, HER2 and Ki67 is important for risk stratification and therapy in breast ca...